Lakatos Péter László, Bajnok Eva, Tornai István, Folhoffer Anikó, Horváth Andrea, Lakatos Péter, Szalay Ferenc
Semmelweis Egyetem, Altalános Orvostudományi Kar, I. sz. Belgyógyászati Klinika, Budapest.
Orv Hetil. 2004 Feb 15;145(7):331-6.
Genetic factors have been implicated in the pathogenesis of osteoporosis, which is a common disorder in primary biliary cirrhosis (PBC). Insulin-like growth factor I (IGF-I) gene microsatellite repeat polymorphism was found to be associated with osteoporosis in some studies and collagen type I alpha 1 (COLIA1) SP1 "s" allele was associated with lower bone mineral density (BMD) in PBC. IGF-I treatment restored osteopenia and reduced fibrogenesis in experimental cirrhosis. We investigated IGF-I and COLIA1 gene polymorphisms and BMD in Hungarian PBC patients.
70 female patients with PBC were enrolled (mean age: 57.6 yrs, range: 37-76 yrs, each AMA M2 positive, stage II-IV). 139 age-matched female subjects served as controls (mean age: 55.9 yrs, range: 43-72 yrs). COLIA1 and IGF-I microsatellite repeat polymorphisms were determined by PCR. Bone mineral density (BMD) was measured by dual energy x-ray absorptiometry (Lunar, Prodigy, WI, USA) in lumbar spine (LS) and femoral neck (FN).
The IGF-I polymorphism was not different between PBC patients (192/192 = 34.2%, 194/192 = 28.6%, other = 37.2%) and controls (192/192 = 38.2%, 194/192 = 30.9%, other = 30.9%). The genotype frequency of COLIA1 polymorphism was also not different between PBC patients (SS = 72.9%, Ss = 22.8% and ss = 4.3%) and controls (SS = 58.4%, Ss = 35.9% and ss = 5.7%), however the "s" allele was significantly less frequent in patients with PBC (p = 0.038). Osteoporosis was present in 22 patients (31.4%). The IGF-I 192/192 allele was associated with higher FN Z-score compared to other genotypes (p = 0.036).
In contrast to previous studies the "s" allele was less frequent in patients with PBC, and its presence was not associated with lower bone mineral density. Since IGF-I polymorphism was associated to BMD, it may be hypothesized that IGF-I microsatellite repeat polymorphism together with other genetic and environmental factors may be involved in the complex regulation of BMD in PBC.
遗传因素已被认为与骨质疏松症的发病机制有关,骨质疏松症是原发性胆汁性肝硬化(PBC)中的一种常见病症。在一些研究中发现胰岛素样生长因子I(IGF-I)基因微卫星重复多态性与骨质疏松症相关,并且I型胶原α1(COLIA1)SP1 “s” 等位基因与PBC患者较低的骨密度(BMD)相关。IGF-I治疗可恢复实验性肝硬化中的骨质减少并减少纤维化。我们调查了匈牙利PBC患者的IGF-I和COLIA1基因多态性以及BMD。
纳入70例PBC女性患者(平均年龄:57.6岁,范围:37 - 76岁,均AMA M2阳性,II - IV期)。139名年龄匹配的女性受试者作为对照(平均年龄:55.9岁,范围:43 - 72岁)。通过PCR测定COLIA1和IGF-I微卫星重复多态性。采用双能X线吸收法(美国威斯康星州Lunar公司的Prodigy)测量腰椎(LS)和股骨颈(FN)的骨密度(BMD)。
PBC患者(192/192 = 34.2%,194/192 = 28.6%,其他 = 37.2%)与对照组(192/192 = 38.2%,194/192 = 30.9%,其他 = 30.9%)之间的IGF-I多态性无差异。PBC患者(SS = 72.9%,Ss = 22.8%,ss = 4.3%)与对照组(SS = 58.4%,Ss = 35.9%,ss = 5.7%)之间COLIA1多态性的基因型频率也无差异,然而PBC患者中 “s” 等位基因的频率显著更低(p = 0.038)。22例患者(31.4%)存在骨质疏松症。与其他基因型相比,IGF-I 192/192等位基因与更高的股骨颈Z值相关(p = 0.036)。
与先前的研究相反,PBC患者中 “s” 等位基因的频率更低,并且其存在与较低的骨密度无关。由于IGF-I多态性与BMD相关,因此可以推测IGF-I微卫星重复多态性与其他遗传和环境因素可能参与了PBC中BMD的复杂调节。